Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1)

Eiji Oki; Yasunori Emi; Yuji Miyamoto; Akira Kabashima; Hidefumi Higashi; Yutaka Ogata; Masahiko Ikebe; Hiroshi Saeki; Shoji Tokunaga; Ken Shirabe; Toru Beppu; Shinji Uchida; Mitsuhisa Takatsuki; Masahiko Sakoda; Susumu Eguchi; Yoshito Akagi; Yoshihiro Kakeji; Hideo Baba; Shoji Natsugoe; Yoshihiko Maehara

doi:10.1245/s10434-015-4864-x

Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1)

Eiji Oki, Yasunori Emi, Yuji Miyamoto, Akira Kabashima, Hidefumi Higashi, Yutaka Ogata, Masahiko Ikebe, Hiroshi Saeki, Shoji Tokunaga, Ken Shirabe, Toru Beppu, Shinji Uchida, Mitsuhisa Takatsuki, Masahiko Sakoda, Susumu Eguchi, Yoshito Akagi, Yoshihiro Kakeji, Hideo Baba, Shoji Natsugoe, Yoshihiko Maehara

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	1617
Number of pages	1
Journal	Annals of Surgical Oncology
Volume	22
DOIs	https://doi.org/10.1245/s10434-015-4864-x
Publication status	Published - Dec 1 2015

All Science Journal Classification (ASJC) codes

Surgery
Oncology

Access to Document

10.1245/s10434-015-4864-x

Cite this

Oki, E., Emi, Y., Miyamoto, Y., Kabashima, A., Higashi, H., Ogata, Y., Ikebe, M., Saeki, H., Tokunaga, S., Shirabe, K., Beppu, T., Uchida, S., Takatsuki, M., Sakoda, M., Eguchi, S., Akagi, Y., Kakeji, Y., Baba, H., Natsugoe, S., & Maehara, Y. (2015). Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1). Annals of Surgical Oncology, 22, 1617. https://doi.org/10.1245/s10434-015-4864-x

Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1). / Oki, Eiji; Emi, Yasunori; Miyamoto, Yuji; Kabashima, Akira; Higashi, Hidefumi; Ogata, Yutaka; Ikebe, Masahiko; Saeki, Hiroshi; Tokunaga, Shoji; Shirabe, Ken; Beppu, Toru; Uchida, Shinji; Takatsuki, Mitsuhisa; Sakoda, Masahiko; Eguchi, Susumu; Akagi, Yoshito; Kakeji, Yoshihiro; Baba, Hideo; Natsugoe, Shoji; Maehara, Yoshihiko.

In: Annals of Surgical Oncology, Vol. 22, 01.12.2015, p. 1617.

Research output: Contribution to journal › Comment/debate › peer-review

Oki, E, Emi, Y, Miyamoto, Y, Kabashima, A, Higashi, H, Ogata, Y, Ikebe, M, Saeki, H, Tokunaga, S, Shirabe, K, Beppu, T, Uchida, S, Takatsuki, M, Sakoda, M, Eguchi, S, Akagi, Y, Kakeji, Y, Baba, H, Natsugoe, S & Maehara, Y 2015, 'Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1)', Annals of Surgical Oncology, vol. 22, pp. 1617. https://doi.org/10.1245/s10434-015-4864-x

Oki E, Emi Y, Miyamoto Y, Kabashima A, Higashi H, Ogata Y et al. Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1). Annals of Surgical Oncology. 2015 Dec 1;22:1617. https://doi.org/10.1245/s10434-015-4864-x

Oki, Eiji ; Emi, Yasunori ; Miyamoto, Yuji ; Kabashima, Akira ; Higashi, Hidefumi ; Ogata, Yutaka ; Ikebe, Masahiko ; Saeki, Hiroshi ; Tokunaga, Shoji ; Shirabe, Ken ; Beppu, Toru ; Uchida, Shinji ; Takatsuki, Mitsuhisa ; Sakoda, Masahiko ; Eguchi, Susumu ; Akagi, Yoshito ; Kakeji, Yoshihiro ; Baba, Hideo ; Natsugoe, Shoji ; Maehara, Yoshihiko. / Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1). In: Annals of Surgical Oncology. 2015 ; Vol. 22. pp. 1617.

@article{daa7e5bf300440b2a0e6c78754231cee,

title = "Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1)",

author = "Eiji Oki and Yasunori Emi and Yuji Miyamoto and Akira Kabashima and Hidefumi Higashi and Yutaka Ogata and Masahiko Ikebe and Hiroshi Saeki and Shoji Tokunaga and Ken Shirabe and Toru Beppu and Shinji Uchida and Mitsuhisa Takatsuki and Masahiko Sakoda and Susumu Eguchi and Yoshito Akagi and Yoshihiro Kakeji and Hideo Baba and Shoji Natsugoe and Yoshihiko Maehara",

year = "2015",

month = dec,

day = "1",

doi = "10.1245/s10434-015-4864-x",

language = "English",

volume = "22",

pages = "1617",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

}

TY - JOUR

T1 - Erratum to Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002) (Ann Surg Oncol, (2015), 10.1245/s10434-015-4771-1)

AU - Oki, Eiji

AU - Emi, Yasunori

AU - Miyamoto, Yuji

AU - Kabashima, Akira

AU - Higashi, Hidefumi

AU - Ogata, Yutaka

AU - Ikebe, Masahiko

AU - Saeki, Hiroshi

AU - Tokunaga, Shoji

AU - Shirabe, Ken

AU - Beppu, Toru

AU - Uchida, Shinji

AU - Takatsuki, Mitsuhisa

AU - Sakoda, Masahiko

AU - Eguchi, Susumu

AU - Akagi, Yoshito

AU - Kakeji, Yoshihiro

AU - Baba, Hideo

AU - Natsugoe, Shoji

AU - Maehara, Yoshihiko

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84952875198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952875198&partnerID=8YFLogxK

U2 - 10.1245/s10434-015-4864-x

DO - 10.1245/s10434-015-4864-x

M3 - Comment/debate

AN - SCOPUS:84952875198

VL - 22

SP - 1617

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -